NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) › Cash & EquivalentsNEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2016: $522.2K2017: $26.5K2018: $13.3K2019: $260.7K2020: $4.04M2021: $6.90M2022: $8.16M2023: $5.32M2024: $1.46M2025: $6.57M$6.57M2016Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$6.57M+350.0%2024$1.46M-72.6%2023$5.32M-34.8%2022$8.16M+18.2%2021$6.90M+71.0%2020$4.04M+1448.0%2019$260.7K+1866.4%2018$13.3K-49.9%2017$26.5K-94.9%2016$522.2K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share